Table 1.
Blood chemistries at presentation and over follow-up (patient 1)
| Admission | Discharge | Middle follow-up | Final follow-up | |
| Creatinine (0.5-1.2, mg/dL) | 2.8 | 1.59 | 1.76 | 0.8 |
| Blood urea nitrogen (8-20, mg/dL) | 147 | 104 | 86 | 85 |
| AST (5-32, IU/L) | 12 | 24 | 27 | 23 |
| ALT (5-31, IU/L) | 9 | 43 | 39 | 7 |
| γGT (5-36, IU/L) | 12 | 44 | 41 | 69 |
| Cholinesterasis (5300-12900, IU/L) | 3833 | 2160 | 2920 | 3173 |
| Total bilirubin (0.2-1.1, mg/dL) | 0.2 | 0.25 | 0.22 | 0.23 |
| Direct bilirubin (0-0.3, mg/dL) | 0.09 | 0.07 | 0.08 | 0.16 |
| Total protein (6.6-8.7, g/dL) | 3.9 | 4.6 | 4.6 | 4.5 |
| Albumin (3.4-4.8, g/dL) | 2.4 | 3 | 2.5 | 3 |
| Prothrombin time (0.88-1.16) | 1.08 | 1.07 | 1.06 | 1.08 |
| Partial thromboplastin time (0.85-1.18) | 1.01 | 1 | 1.03 | 1.19 |
| C3 (90-180) | 20 | 56 | 59 | 99 |
| C4 (10-40) | 0 | 1 | 3 | 2 |
| Cryoglobulins | Present | Absent | Absent | Present |
| Leucocytes (4.8-10.8, 103/mmc) | 10670 | 3440 | 3400 | 3730 |
| Hemoglobin (12-16, g/dL) | 10.8 | 9.7 | 10.2 | 10.5 |
| Platelets (130-400, 103/mmc) | 313000 | 159000 | 153000 | 73000 |
AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; γGT: Gamma-glutamyl transpeptidase.